Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01588691 · ClinicalTrials.gov registry record · Phase 1
Traumatic Brain Injury Peripheral Nerve Study
A Phase 1 study of Traumatic Brain Injury, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- Phase 1
- Development phase
- 3
- Enrollment target
- 1
- Study location
NCT01588691: Completed Phase 1 study of Traumatic Brain Injury, sponsored by Abbott Medical Devices.
NCT01588691 is a Phase 1 study of Traumatic Brain Injury that has completed, run by Abbott Medical Devices. The registered enrollment target is 3 participants, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01588691, a Phase 1 study of Traumatic Brain Injury, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 3 participants
- Enrollment target
- 1
- Study location
Study Summary
Peripheral nerve stimulation for the treatment of sequelae due to traumatic brain injury. This study will specifically examine patients with mild traumatic brain injury (TBI) who have persistent cognitive impairments lasting one year or longer. Neuropsychological testing will occur to confirm the diagnosis.
Conditions Studied
Interventions
- DEVICE Eon-mini IPG (implantable pulse generator)
Study Locations (1)
California
- Kevin Yoo, MD/Palomar Neurosurgery Ctr - Poway
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2011-12 |
| Est. Completion | 2014-11 |
| Phase | Phase 1 |
What the finished NCT01588691 record still lists
NCT01588691 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Traumatic Brain Injury appearing as the primary indexed condition, and to 1 intervention - of which Eon-mini IPG (implantable pulse generator) is the first listed.
NCT01588691 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01588691 about?
NCT01588691 is a clinical study titled "Traumatic Brain Injury Peripheral Nerve Study". Peripheral nerve stimulation for the treatment of sequelae due to traumatic brain injury. This study will specifically examine patients with mild traumatic brain injury (TBI) who have persistent cognitive impairments lasting one year or longer. Neuropsychological testing will occur to confirm the di...
What is the current status of trial NCT01588691?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 3 participants. The study started on 2011-12. Estimated completion is 2014-11.
What conditions does trial NCT01588691 study?
This clinical trial studies the following conditions: Traumatic Brain Injury.
What interventions are being tested in trial NCT01588691?
The interventions under investigation include: Eon-mini IPG (implantable pulse generator) (DEVICE).
Who is sponsoring clinical trial NCT01588691?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01588691 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Traumatic Brain Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01588691's enrollment target sits among peer trials
3 171st of 171 higher than 1 of 171 other Traumatic Brain Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Traumatic Brain Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Hyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury
RECRUITING · Phase 1
-
Safety and Efficacy of Angiotensin (1-7) in Persons With Moderate to Severe Traumatic Brain Injury
RECRUITING · Phase 1
-
Combinatory Rehabilitation Used for Substantially Helping Individuals With Traumatic Brain Injury
RECRUITING · Phase 1
-
Safety Study of RP-1127 (Glyburide for Injection) in Healthy Volunteers
COMPLETED · Phase 1
-
Functional Connectivity as a Biomarker of rTMS
COMPLETED · Phase 1
-
Effects of TT301 on Cytokine Levels Post Endotoxin Challenge
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia